Dallas—Peloton Therapeutics, which is developing small molecule drugs to treat cancer, announced Wednesday that it has raised $150 million in a Series E funding round. The new financing was led by RA Capital Management and was joined by new investors, including Eventide Asset Management, Biotechnology Value Fund, OrbiMed, EcoR1 Capital, Vida Ventures, Curative Ventures, and […]